512 related articles for article (PubMed ID: 37045827)
1. Patient-derived xenograft models in cancer therapy: technologies and applications.
Liu Y; Wu W; Cai C; Zhang H; Shen H; Han Y
Signal Transduct Target Ther; 2023 Apr; 8(1):160. PubMed ID: 37045827
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
3. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
Okada S; Vaeteewoottacharn K; Kariya R
Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
[TBL] [Abstract][Full Text] [Related]
4. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
[TBL] [Abstract][Full Text] [Related]
5. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
[TBL] [Abstract][Full Text] [Related]
7. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
[TBL] [Abstract][Full Text] [Related]
8. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance.
Shi J; Li Y; Jia R; Fan X
Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
Bonazzi VF; Kondrashova O; Smith D; Nones K; Sengal AT; Ju R; Packer LM; Koufariotis LT; Kazakoff SH; Davidson AL; Ramarao-Milne P; Lakis V; Newell F; Rogers R; Davies C; Nicklin J; Garrett A; Chetty N; Perrin L; Pearson JV; Patch AM; Waddell N; Pollock PM
Genome Med; 2022 Jan; 14(1):3. PubMed ID: 35012638
[TBL] [Abstract][Full Text] [Related]
10. Humanized mouse models for anti-cancer therapy.
Baietti MF; Leucci E
Methods Cell Biol; 2024; 183():317-333. PubMed ID: 38548416
[TBL] [Abstract][Full Text] [Related]
11. [Knowledge and practice of patient-derived xenograft models in leukemia].
Kato I
Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
[TBL] [Abstract][Full Text] [Related]
12. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
Wang Z; Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
Sun S; Zhang Z
Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
[TBL] [Abstract][Full Text] [Related]
14. [Drug Development Based on Intracellular Pharmacokinetic Analysis of Molecular Target Drug in Mice Bearing Patient-derived Xenograft Model].
Hamada A
Yakugaku Zasshi; 2020; 140(5):641-648. PubMed ID: 32378664
[TBL] [Abstract][Full Text] [Related]
15. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
[TBL] [Abstract][Full Text] [Related]
16. Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model.
Wu Y; Wang J; Zheng X; Chen Y; Huang M; Huang Q; Xiao W; Wei H; Tian Z; Sun R; Sun C
Immunol Lett; 2020 Jul; 223():33-43. PubMed ID: 32335145
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
[TBL] [Abstract][Full Text] [Related]
18. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Dobrolecki LE; Airhart SD; Alferez DG; Aparicio S; Behbod F; Bentires-Alj M; Brisken C; Bult CJ; Cai S; Clarke RB; Dowst H; Ellis MJ; Gonzalez-Suarez E; Iggo RD; Kabos P; Li S; Lindeman GJ; Marangoni E; McCoy A; Meric-Bernstam F; Piwnica-Worms H; Poupon MF; Reis-Filho J; Sartorius CA; Scabia V; Sflomos G; Tu Y; Vaillant F; Visvader JE; Welm A; Wicha MS; Lewis MT
Cancer Metastasis Rev; 2016 Dec; 35(4):547-573. PubMed ID: 28025748
[TBL] [Abstract][Full Text] [Related]
20. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
